A multi-provider gastroenterology practice agreed to pay $4.75 million to settle DOJ allegations of kickbacks and unnecessary pathology billing—a reminder that billing compliance risk is accelerating in specialty practices.

This settlement signals renewed DOJ focus on pathology billing abuse and improper referral arrangements in gastroenterology, a high-margin specialty where in-office lab and pathology services are common. The $4.75 million penalty suggests a multi-year investigation with substantial claims exposure. For practice owners and gastroenterology groups, this is a direct operational threat: billing practices that may have seemed routine (markup on pathology, lab bundles, referral incentives) are now enforcement priorities. The Justice Department is actively investigating specialty practices, not just hospitals. Even mid-size groups are exposed.

Implications are immediate for any DSO or specialty practice using third-party pathology vendors or maintaining in-office lab services. Audit your billing practices for: (1) whether pathology charges are medically necessary or inflated, (2) whether any referral arrangements could be construed as kickbacks, and (3) whether lab coding aligns with actual procedures performed. Non-compliance can trigger civil fraud liability (treble damages) plus exclusion from Medicare. This is not a legal gray area anymore—DOJ settlements are public signals of enforcement appetite. For dental practices: while this is GI-specific, the compliance lesson applies broadly. If you operate in-house diagnostics or refer to in-house labs, ensure nothing resembles a financial incentive tied to referral volume.

Watch: Whether additional GI practices are named in DOJ settlements or qui tam filings over the next 6 months, signaling scope of investigation.